Zoladex · DIN 02049325 · 3.6 mg · Depot injection
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Zoladex · DIN 02049325
Manufacturer: TerSera Therapeutics LLC; listing date 1996-10-01
Health Canada: Marketed since 2018-02-28 · brand ZOLADEX · ATC L02AE03 GOSERELIN · form Implant · route Subcutaneous · ingredients GOSERELIN (GOSERELIN ACETATE) 3.6 MG · company Activated environmental solutions, inc. · schedule Prescription
Zoladex: Formulary list price $422.68 per unit (the source does not state the unit; exact figure $422.6778). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02049325)
Source record
DIN 02049325: Zoladex
Raw flags: sec3=Y
Item: 100000069; group id 166; item number 0281; lccId None; manufacturer id TRS
Source form: Depot Inj; strength: 3.6mg
Recorded listing: General benefit
Source prices (unrounded): $422.6778; ministry $422.6778
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02049325
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16216
Shortage status: not checked (no credentials)